Clinical Trials in New York

Showing 5621-5640 of 22,668 trials

Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma

NCT03117309

Phase II trial of nivolumab in 120 treatment naïve patients with ccRCC.

Michael B. Atkins, MD164 participantsStarted Apr 2017

New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States • Atlanta, Georgia, United States +9 more locations

Active Not RecruitingPhase 3< 1 mile

RNS System NAUTILUS Study

NCT05147571

To demonstrate that the RNS System for thalamic stimulation is safe and effective as an adjunctive therapy for the reduction of primary generalized seizures in individuals 12 years of age or older who have drug-resistant idiopathic generalized epilepsy.

EpilepsyIdiopathic Generalized EpilepsyGeneralized Tonic Clonic Seizure

NeuroPace100 participantsStarted Aug 2022

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Aurora, Colorado, United States +20 more locations

Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma

RNS System NAUTILUS Study

Find Trials by Condition in New York

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis

Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer

Kaneka iED Coil System for the Treatment of Wide Necked Ruptured and Unruptured Intracranial Aneurysms

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT

The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)

A Study in Participants With Non-cirrhotic NASH With Fibrosis

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo

Observational Maternal COVID-19 Vaccination Study

Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease

LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)